Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
RogCon, Inc. logo — The SCN2A Company

RogCon, Inc.

The SCN2A Company

Founded 2015 United States Miami, United States 7 employees Biotechnology, Health Care +1

General Information

Company Name RogCon, Inc.
Founded Year 2015
Location United States Miami, United States
Employees 7
Industries Biotechnology, Health Care, Health and Wellness
Social

BounceWatch is an independent company data service, not affiliated with RogCon, Inc.. To contact RogCon, Inc., visit rogcon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About RogCon, Inc.

RogCon, Inc., also known as "The SCN2A Company," is a biotechnology firm founded in 2015, headquartered in the United States, and specializing in drug research, discovery, and development for select ion channelopathies. With a primary focus on SCN2A, the company operates within the biotechnology and health care sectors. Although there is no publicly available information regarding the last investment round and the associated investors, RogCon, Inc.'s dedicated focus on SCN2A and its activities in drug development position it as a promising player in the biotechnology and health care industries.

Taxonomy: drug research, ion channelopathies, SCN2A, drug discovery, drug development, neurological disorders, genetic diseases, biopharmaceuticals, ion channels, neuroscience, precision medicine, pharmaceutical industry, clinical trials, medical research

No funding data available for RogCon, Inc. yet.

RogCon, Inc. Alternatives & Competitors

View All Alternatives
RogCon, Inc. vs
Autifony Therapeutics
Autifony Therapeutics

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

Venture round
37 employees
Biotechnology, Health and Wellness
Compare RogCon, Inc. vs Autifony Therapeutics
RogCon, Inc. vs
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. Canada

A neuroscience-focused biopharmaceutical company

Post-IPO Equity
333 employees
Biopharma, Biotechnology
RogCon, Inc. vs
iN Therapeutics
iN Therapeutics Korea South

의학 및 약학 연구개발업

Series B
8 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About RogCon, Inc.

The SCN2A Company
RogCon, Inc. was founded in 2015.
RogCon, Inc. is headquartered in Miami, United States.
RogCon, Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on drug research, ion channelopathies, SCN2A and drug discovery.
RogCon, Inc. has approximately 7 employees.
Top alternatives and competitors to RogCon, Inc. include Autifony Therapeutics, Xenon Pharmaceuticals Inc., iN Therapeutics, Corlieve Therapeutics, Cerevance. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RogCon, Inc. and Autifony Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RogCon, Inc., https://bouncewatch.com/company/rogcon-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes